Related Experiment Video
Updated: Nov 22, 2025

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
RMRP, RMST, FTX and IPW: novel potential long non-coding RNAs in medullary thyroid cancer
Berta Luzón-Toro1,2, Leticia Villalba-Benito1,2, Raquel María Fernández1,2
1Department of Maternofetal Medicine, Genetics and Reproduction, Institute of Biomedicine of Seville (IBIS), University Hospital Virgen del Rocío/CSIC, University of Seville, Seville, Spain.
Abstract:
The relevant role of long non-coding RNAs (lncRNAs) in cancer is currently a matter of increasing interest. Medullary thyroid cancer (MTC) is a rare neuroendocrine tumor (2-5% of all thyroid cancer) derived from the parafollicular C-cells which secrete calcitonin. About 75% of all medullary thyroid cancers are believed to be sporadic medullary thyroid cancer (sMTC), whereas the remaining 25% correspond to inherited cancer syndromes known as Multiple Endocrine Neoplasia type 2 (MEN2). MEN2 syndrome, with autosomal dominant inheritance is caused by germline gain of function mutations in RET proto-oncogene. To date no lncRNA has been associated to MEN2 syndrome and only two articles have been published relating long non-coding RNA (lncRNA) to MTC: the first one linked MALAT1 with sMTC and, in the other, our group determined some new lncRNAs in a small group of sMTC cases in fresh tissue (RMST, FTX, IPW, PRNCR1, ADAMTS9-AS2 and RMRP). The aim of the current study is to validate such novel lncRNAs previously described by our group by using a larger cohort of patients, in order to discern their potential role in the disease. Here we have tested three up-regulated (RMST, FTX, IPW) and one down-regulated (RMRP) lncRNAs in our samples (formalin fixed paraffin embedded tissues from twenty-one MEN2 and ten sMTC patients) by RT-qPCR analysis. The preliminary results reinforce the potential role of RMST, FTX, IPW and RMRP in the pathogenesis of MTC.
Insights
This study validates novel long non-coding RNAs (lncRNAs) in medullary thyroid cancer (MTC). Preliminary results suggest RMST, FTX, IPW, and RMRP play a role in MTC pathogenesis.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Medullary thyroid cancer (MTC) is a rare neuroendocrine tumor with sporadic (sMTC) and inherited (MEN2) forms.
- Multiple Endocrine Neoplasia type 2 (MEN2) is linked to RET proto-oncogene mutations.
- Long non-coding RNAs (lncRNAs) are increasingly recognized for their role in cancer, but their involvement in MEN2 is unexplored.
Discussion:
- This study validates previously identified lncRNAs (RMST, FTX, IPW, RMRP) in a larger cohort of MTC patients.
- RT-qPCR analysis was performed on formalin-fixed paraffin-embedded tissues from MEN2 and sMTC patients.
- The expression levels of RMST, FTX, and IPW were found to be up-regulated, while RMRP was down-regulated.
Key Insights:
- RMST, FTX, and IPW show potential as up-regulated biomarkers in MTC pathogenesis.
- RMRP demonstrates potential as a down-regulated biomarker in MTC pathogenesis.
- These findings support the involvement of specific lncRNAs in the development of MTC.
Outlook:
- Further research is needed to elucidate the precise mechanisms by which these lncRNAs influence MTC.
- Validation in larger, diverse patient cohorts and functional studies are crucial.
- These lncRNAs may represent novel therapeutic targets or diagnostic markers for MTC.
More Related Videos
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
11:11Desthiobiotin-Streptavidin-Affinity Mediated Purification of RNA-Interacting Proteins in Mesothelioma Cells
Published on: April 25, 2018
Related Concept Videos
lncRNA - Long Non-coding RNAs
MicroRNAs
MicroRNAs
Non-LTR Retrotransposons
mTOR Signaling and Cancer Progression
The mTOR pathway or the...